CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, Weissman IL.
Barkal AA, et al. Among authors: krishnan v.
Nature. 2019 Aug;572(7769):392-396. doi: 10.1038/s41586-019-1456-0. Epub 2019 Jul 31.
Nature. 2019.
PMID: 31367043
Free PMC article.